These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 1580805)

  • 1. Detection and staging of dementia in Alzheimer's disease. Use of the neuropsychological measures developed for the Consortium to Establish a Registry for Alzheimer's Disease.
    Welsh KA; Butters N; Hughes JP; Mohs RC; Heyman A
    Arch Neurol; 1992 May; 49(5):448-52. PubMed ID: 1580805
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of abnormal memory decline in mild cases of Alzheimer's disease using CERAD neuropsychological measures.
    Welsh K; Butters N; Hughes J; Mohs R; Heyman A
    Arch Neurol; 1991 Mar; 48(3):278-81. PubMed ID: 2001185
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Detection of early cases of Alzheimer's disease. Application of the CERAD neuropsychological test battery].
    Larumbe R
    Rev Med Univ Navarra; 1997; 41(1):6-11. PubMed ID: 9527716
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cognitive test performance in detecting, staging, and tracking Alzheimer's disease.
    Locascio JJ; Growdon JH; Corkin S
    Arch Neurol; 1995 Nov; 52(11):1087-99. PubMed ID: 7487561
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part V. A normative study of the neuropsychological battery.
    Welsh KA; Butters N; Mohs RC; Beekly D; Edland S; Fillenbaum G; Heyman A
    Neurology; 1994 Apr; 44(4):609-14. PubMed ID: 8164812
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bihemispheric cerebral FDG PET correlates of cognitive dysfunction as assessed by the CERAD in Alzheimer's disease.
    Schönknecht OD; Hunt A; Toro P; Guenther T; Henze M; Haberkorn U; Schröder J
    Clin EEG Neurosci; 2011 Apr; 42(2):71-6. PubMed ID: 21675596
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part I. Clinical and neuropsychological assessment of Alzheimer's disease.
    Morris JC; Heyman A; Mohs RC; Hughes JP; van Belle G; Fillenbaum G; Mellits ED; Clark C
    Neurology; 1989 Sep; 39(9):1159-65. PubMed ID: 2771064
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and neuropsychological differences between patients with earlier and later onset of Alzheimer's disease: A CERAD analysis, Part XII.
    Koss E; Edland S; Fillenbaum G; Mohs R; Clark C; Galasko D; Morris JC
    Neurology; 1996 Jan; 46(1):136-41. PubMed ID: 8559362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cognitive functioning in late-life schizophrenia: a comparison of elderly schizophrenic patients and patients with Alzheimer's disease.
    Davidson M; Harvey P; Welsh KA; Powchik P; Putnam KM; Mohs RC
    Am J Psychiatry; 1996 Oct; 153(10):1274-9. PubMed ID: 8831434
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of the CERAD-NP on diagnosis of cognitive deficiencies in late onset depression and Alzheimer's disease.
    Künig G; Jäger M; Stief V; Kaldune A; Urbaniok F; Endrass J
    Int J Geriatr Psychiatry; 2006 Oct; 21(10):911-6. PubMed ID: 16927401
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The relationship between extrapyramidal signs and cognitive performance in patients with Alzheimer's disease enrolled in the CERAD Study. Consortium to Establish a Registry for Alzheimer's Disease.
    Clark CM; Ewbank D; Lerner A; Doody R; Henderson VW; Panisset M; Morris JC; Fillenbaum GG; Heyman A
    Neurology; 1997 Jul; 49(1):70-5. PubMed ID: 9222172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Validation of the Short Cognitive Battery (B2C). Value in screening for Alzheimer's disease and depressive disorders in psychiatric practice].
    Robert PH; Schuck S; Dubois B; Lépine JP; Gallarda T; Olié JP; Goni S; Troy S
    Encephale; 2003; 29(3 Pt 1):266-72. PubMed ID: 12876552
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Frontotemporal dementia, semantic dementia, and Alzheimer's disease: the contribution of standard neuropsychological tests to differential diagnosis.
    Diehl J; Monsch AU; Aebi C; Wagenpfeil S; Krapp S; Grimmer T; Seeley W; Förstl H; Kurz A
    J Geriatr Psychiatry Neurol; 2005 Mar; 18(1):39-44. PubMed ID: 15681627
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Addenbrooke's cognitive examination III: diagnostic utility for mild cognitive impairment and dementia and correlation with standardized neuropsychological tests.
    Matias-Guiu JA; Cortés-Martínez A; Valles-Salgado M; Rognoni T; Fernández-Matarrubia M; Moreno-Ramos T; Matías-Guiu J
    Int Psychogeriatr; 2017 Jan; 29(1):105-113. PubMed ID: 27682860
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In Thai Nationals, the ApoE4 Allele Affects Multiple Domains of Neuropsychological, Biobehavioral, and Social Functioning Thereby Contributing to Alzheimer's Disorder, while the ApoE3 Allele Protects Against Neuropsychiatric Symptoms and Psychosocial Deficits.
    Tangwongchai S; Supasitthumrong T; Hemrunroj S; Tunvirachaisakul C; Chuchuen P; Houngngam N; Snabboon T; Tawankanjanachot I; Likitchareon Y; Phanthumchindad K; Maes M
    Mol Neurobiol; 2018 Aug; 55(8):6449-6462. PubMed ID: 29307083
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characteristics of Mild Cognitive Impairment Using the Thai Version of the Consortium to Establish a Registry for Alzheimer's Disease Tests: A Multivariate and Machine Learning Study.
    Tunvirachaisakul C; Supasitthumrong T; Tangwongchai S; Hemrunroj S; Chuchuen P; Tawankanjanachot I; Likitchareon Y; Phanthumchinda K; Sriswasdi S; Maes M
    Dement Geriatr Cogn Disord; 2018; 45(1-2):38-48. PubMed ID: 29617684
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The consortium to establish a registry for Alzheimer's disease (CERAD). Part IV. Rates of cognitive change in the longitudinal assessment of probable Alzheimer's disease.
    Morris JC; Edland S; Clark C; Galasko D; Koss E; Mohs R; van Belle G; Fillenbaum G; Heyman A
    Neurology; 1993 Dec; 43(12):2457-65. PubMed ID: 8255439
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The neuropsychological profiles of mild Alzheimer's disease and questionable dementia as compared to age-related cognitive decline.
    Vliet EC; Manly J; Tang MX; Marder K; Bell K; Stern Y
    J Int Neuropsychol Soc; 2003 Jul; 9(5):720-32. PubMed ID: 12901778
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CERAD test performance and cognitive impairment in Parkinson's disease.
    Karrasch M; Laatu S; Martikainen K; Marttila R
    Acta Neurol Scand; 2013 Dec; 128(6):409-13. PubMed ID: 23668316
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CERAD test performances in amnestic mild cognitive impairment and Alzheimer's disease.
    Karrasch M; Sinervä E; Grönholm P; Rinne J; Laine M
    Acta Neurol Scand; 2005 Mar; 111(3):172-9. PubMed ID: 15691286
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.